This federal contract award, valued at $3,710.99, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Vyvanse 40 mg capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD).
The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary mechanism for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition.
Generated 3/5/25, 9:59 AM